Invitrogen/Life Technologies (C): The Best Owner of the Asset

Invitrogen/Life Technologies (C): The Best Owner of the Asset

By
Robert Burgelman, Robert Siegel, Rosy Lee
2014|Case No.SM209C| Length 3 pgs.

This short case discusses the process of Life Technologies’ acquisition by Thermo Fisher in 2013 and 2014. The case is a complement to SM-209A and SM-209B, which highlight the various growth and acquisition strategies the company undertook over the previous 10 years.

Learning Objective
The goal of the case is to complete the story of Invitrogen/Life Technologies as the company was ultimately acquired itself by another firm.
This material is available for download by current Stanford GSB students, faculty, and staff, as well as Stanford GSB alumni. For inquiries, contact the Case Writing Office.